Diabetes

By Dave Muoio September 6, 2018
Diabetes is a costly chronic condition, and according to the International Diabetes Federation affects at least 425 million people worldwide. As such, it’s little surprise that an increasing number of digital health companies have spotted an opportunity to help patients manage and control their disease. In fact, that opportunity led the total revenue digital diabetes market to triple in 2017 to $...
By Jonah Comstock September 5, 2018
Correction: A previous version of this article failed to specify that the deal concerns Freestyle Libre Pro, rather than the consumer version, Freestyle Libre. Livongo Health, the digital chronic disease management company founded by former Allscripts CEO Glen Tullman, announced today that it will be the first United States enterprise diabetes management company to bring Abbott’s Freestyle Libre...
By Dave Muoio July 11, 2018
In 2016, UnitedHealthcare and Medtronic cut a deal that established the latter’s devices as the preferred insulin pumps for United members with diabetes. Now, the companies have announced year one data suggesting that members who took advantage of the companies’ arrangement experienced fewer preventable hospital admissions when compared to members relying on multiple daily injections of insulin...
By Dave Muoio July 9, 2018
Researchers from the University of Waterloo have described a proof-of-concept system that uses Google’s Soli — an experimental, radar-based gesture tracker co-developed with Infineon — to track concentrations of glucoses within a solution. With further investigation and adjustment, this prototype technology could potentially be implemented for diabetes patients as a novel noninvasive approach to...
By Jonah Comstock July 2, 2018
Healthy Interactions, a population health company that offers both digital and in-person programs for chronic disease management and education, announced last week that it has added two new programs, for cardiovascular disease and depression, to its portfolio.  The company's initial focus was on diabetes, and it launched its original program, diabetes self-management education and support, in...
By Jonah Comstock June 25, 2018
Working with digital diabetes prevention program (DPP) provider Omada Health — and combining that intervention with lab and biometric screenings — lab company Quest Diagnostics reduced risk for diabetes in one-third of a 107-employee cohort. "Many employers are eager to implement employee wellness programs that drive better health and cost outcomes, but are unsure of how best to achieve these...
By Dave Muoio June 25, 2018
This weekend saw the kickoff of the American Diabetes Association’s 78th annual conference, and with it a slew of new data from diabetes management players. The meeting included presentation on studies covering a range of technologies, such as continuous glucose monitors, insulin pumps, apps, and other digital-backed management strategies. Among the studies highlighted by the association was an...
By Dave Muoio June 20, 2018
Digital chronic disease management company Omada Health announced today the launch of new programs designed to support individuals with Type 2 diabetes and hypertension. Accompanying these are a set of new features for the enterprise and health plan platform focused on medication adherence and remote monitoring, all of which comprise what a representative from the company described as “the...
DreaMed Diabetes tool gets FDA approval
By Dave Muoio June 18, 2018
The FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes. “This is an innovation that can improve people’s lives and the FDA decision confirms what we believe is an important step in making a more meaningful connection between the healthcare provider and their type 1 diabetes patients...
By Laura Lovett June 11, 2018
Glooko announced the launch of the new version of its Glooko Web Application platform this morning. The site aims to give users more resources with a streamlined navigation tool and an assortment of diabetes analytics, charts, and graphs.  “We are truly excited to supply PWDs and clinicians with the most comprehensive set of reports and analytics on diabetes data available today,” Sam Wyndbrant,...
steroid-pharm.com

http://steroid-pharm.com

виагра инструкция цена